“COVID-19 AND LOW PLATELET COUNT-A RELATIONSHIP”

Abstract 60 | Pdf Downloads 7 | DOI https://doi.org/10.53555/jptcp.v22i3.4433

Page 315-319

TO ASSESS THE EFFICACY OF NAPROXEN AND SULFASALAZINE IN SUBJECTS WITH JUVENILE ONSET ANKYLOSING SPONDYLITIS (10-17 YEARS): A PROSPECTIVE STUDY

Abstract 43 | pdf Downloads 25

Page 303-309

PROGRAMMED DEATH- LIGAND 1 EXPRESSION IN UROTHELIAL CARCINOMA

Abstract 52 | Pdf Downloads 7 | DOI https://doi.org/10.53555/jptcp.v22i3.4417

Page 310-314

Decisions in a Time of Change: New Frontiers in Health Policy, HTAS, and Methods

Abstract 137 | PDF Downloads 155

BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS

Abstract 320 | PDF Downloads 140

COST-SHARING FOR HEALTH CARE SERVICES: AN ALTERNATIVE STRATEGY FOR PHARMACEUTICAL REIMBURSEMENT IN ONTARIO

Abstract 148 | PDF Downloads 117

LA POLYPHARMACIE: ENJEUX METHODOLOGIQUES A CONSIDERER

Abstract 252 | PDF Downloads 311

REGIONAL VARIATIONS IN THE PREVALENCE OF MAJOR CONGENITAL MALFORMATIONS IN QUEBEC: THE IMPORTANCE OF FETAL GROWTH ENVIRONMENT

Abstract 381 | PDF Downloads 158

USING A COMMON FORM FOR CONSISTENT COLLECTION AND REPORTING OF FASD DATA FROM ACROSS CANADA: A FEASIBILITY STUDY

Abstract 371 | PDF Downloads 201

EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING

Abstract 233 | PDF Downloads 141